Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study.
Labreche K, Daniau M, Sud A, Law PJ, Royer-Perron L, Holroyd A, Broderick P, Went M, Benazra M, Ahle G, Soubeyran P, Taillandier L, Chinot OL, Casasnovas O, Bay JO, Jardin F, Oberic L, Fabbro M, Damaj G, Brion A, Mokhtari K, Philippe C, Sanson M, Houillier C, Soussain C, Hoang-Xuan K, Houlston RS, Alentorn A; LOC Network. Labreche K, et al. Among authors: soussain c. Neuro Oncol. 2019 Aug 5;21(8):1039-1048. doi: 10.1093/neuonc/noz088. Neuro Oncol. 2019. PMID: 31102405 Free PMC article.
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patients.
Soussain C, Souleau B, Gabarre J, Zouabi H, Sutton L, Boccaccio C, Albin N, Charlotte F, Merle-Béral H, Delort J, Binet JL, Leblond V. Soussain C, et al. Leuk Lymphoma. 1999 May;33(5-6):543-50. doi: 10.3109/10428199909058458. Leuk Lymphoma. 1999. PMID: 10342581 Clinical Trial.
Recent advances in primary CNS lymphoma.
Hoang-Xuan K, Camilleri-Broët S, Soussain C. Hoang-Xuan K, et al. Among authors: soussain c. Curr Opin Oncol. 2004 Nov;16(6):601-6. doi: 10.1097/01.cco.0000142927.88773.7e. Curr Opin Oncol. 2004. PMID: 15627024 Review.
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
Soussain C, Hoang-Xuan K, Taillandier L, Fourme E, Choquet S, Witz F, Casasnovas O, Dupriez B, Souleau B, Taksin AL, Gisselbrecht C, Jaccard A, Omuro A, Sanson M, Janvier M, Kolb B, Zini JM, Leblond V; Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire. Soussain C, et al. J Clin Oncol. 2008 May 20;26(15):2512-8. doi: 10.1200/JCO.2007.13.5533. Epub 2008 Apr 14. J Clin Oncol. 2008. PMID: 18413641 Clinical Trial.
[Neurological damage of brain tumor therapy].
Ricard D, De Greslan T, Soussain C, Bounolleau P, Sallansonnet-Froment M, Delmas JM, Taillia H, Martin-Duverneuil N, Renard JL, Hoang-Xuan K. Ricard D, et al. Among authors: soussain c. Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):575-87. doi: 10.1016/j.neurol.2008.03.014. Epub 2008 Jun 9. Rev Neurol (Paris). 2008. PMID: 18565357 Review. French.
Primary CNS lymphoma in immunocompetent patients.
Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Sierra del Rio M, et al. Among authors: soussain c. Oncologist. 2009 May;14(5):526-39. doi: 10.1634/theoncologist.2008-0236. Epub 2009 May 11. Oncologist. 2009. PMID: 19433528 Free article. Review.
125 results